Cambrex competitors
Cambrex Competitors include Lonza, Assertio Therapeutics, Aradigm and Albany Molecular Research.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Cambrex Cambrex is an innovative life sciences company with a refreshingly human approach to the way we do business. |  Lonza Lonza supplies active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries. |  Assertio Therapeutics Assertio Therapeutics (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other. |  Aradigm Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases. |  Albany Molecular Research Albany Molecular Research is a pharmaceutical services organization offering Discovery/Development solutions, and Drug Product and API Manufacturing. |
Founding Date | Founding Date 1981 | Founding Date 1897 | Founding Date 1995 | Founding Date 1991 | Founding Date 1991 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations East Rutherford, US HQ | Locations Basel, CH HQ Mt Waverley, AU Verviers, BE São Paulo, BR Suzhou, CN San José, CR Kouřim, CZ see more | Locations Newark, US HQ | Locations Hayward, US HQ | Locations Albany, US HQ |
Employees | Employees 1,228 | Employees 14,618 | Employees 43411% decrease | Employees 23 | Employees N/A |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 16.4 b | Valuation ($) 259 m | Valuation ($) 7.3 m | Valuation ($) N/A |
Twitter followers | Twitter followers N/A | Twitter followers 4.9 k | Twitter followers N/A | Twitter followers 16 | Twitter followers 1.1 k |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) $523.9m (FY, 2017) | Revenue (est.) CHF5.1b (FY, 2017) | Revenue (est.) $380.7m (FY, 2017) | Revenue (est.) $14.5m (FY, 2017) | Revenue (est.) $570.5m (FY, 2016) |
Cost of goods | Cost of goods $304.4m (FY, 2017) | Cost of goods CHF3.3b (FY, 2017) | Cost of goods $72.6m (FY, 2017) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $219.6m (FY, 2017) | Gross profit CHF1.8b (FY, 2017) | Gross profit $308.1m (FY, 2017) | Gross profit N/A | Gross profit N/A |
Net income | Net income $102.5m (FY, 2017) | Net income CHF728m (FY, 2017) | Net income ($102.5m) (FY, 2017) | Net income N/A | Net income ($70.2m) (FY, 2016) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 875m | Total funding raised $ 27.1m | Total funding raised N/A |
For sources of this data, please see the company profileDownload Excel
View company profiles
Lonza
HQ
Basel, CH
Employees
14,618
Lonza supplies active ingredients, chemical intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries.
View companyAssertio Therapeutics
HQ
Newark, US
Employees
434↓ 11% decrease
Assertio Therapeutics (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.
View companyAradigm
HQ
Hayward, US
Employees
23
Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.
View companyAlbany Molecular Research
HQ
Albany, US
Albany Molecular Research is a pharmaceutical services organization offering Discovery/Development solutions, and Drug Product and API Manufacturing.
View company